Article
Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo…
eLife · 2022 · Ning Yang, author Xuebo Lu, author Yanan Jiang, author Lili Zhao, author Donghao Wang, author Yaxing Wei, author Yin Yu, author Myoung Ok Kim, author Kyle Vaughn Laster, author Xin Li, author Baoyin Yuan, author Zigang Dong, author ([email protected]) Kangdong Liu, author ([email protected]) Wafik S El-Deiry, editor Wafik S El-Deiry, senior_editor
Key facts
| Title | Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase |
|---|---|
| First author | Ning Yang, author Xuebo Lu, author Yanan Jiang, author Lili Zhao, author Donghao Wang, author Yaxing Wei, author Yin Yu, author Myoung Ok Kim, author Kyle Vaughn Laster, author Xin Li, author Baoyin Yuan, author Zigang Dong, author ([email protected]) Kangdong Liu, author ([email protected]) Wafik S El-Deiry, editor Wafik S El-Deiry, senior_editor |
| Journal | eLife |
| Published | Sep 9, 2022 |
| DOI | 10.7554/eLife.73953 |
| Product codes mentioned | GIA |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1